BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28493882)

  • 1. Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    Alam S; Chan C; Qiu X; Shannon I; White CL; Sant AJ; Nayak JL
    PLoS One; 2017; 12(5):e0176407. PubMed ID: 28493882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.
    Nayak JL; Fitzgerald TF; Richards KA; Yang H; Treanor JJ; Sant AJ
    J Infect Dis; 2013 Jan; 207(2):297-305. PubMed ID: 23148285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: Heterosubtypic influenza infection antagonizes elicitation of immunological reactivity to hemagglutinin.
    Nayak JL; Alam S; Sant AJ
    J Immunol; 2013 Aug; 191(3):1001-5. PubMed ID: 23794632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Vaccination Directs the CD4
    Rattan A; Richards KA; Knowlden ZAG; Sant AJ
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
    Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
    Front Immunol; 2019; 10():1400. PubMed ID: 31312199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
    Richards KA; Topham D; Chaves FA; Sant AJ
    J Immunol; 2010 Nov; 185(9):4998-5002. PubMed ID: 20889549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.
    Yang J; James E; Gates TJ; DeLong JH; LaFond RE; Malhotra U; Kwok WW
    Int Immunol; 2013 Aug; 25(8):447-57. PubMed ID: 23524391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
    Richards KA; Chaves FA; Sant AJ
    J Virol; 2009 Jul; 83(13):6566-77. PubMed ID: 19386707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.
    Faenzi E; Zedda L; Bardelli M; Spensieri F; Borgogni E; Volpini G; Buricchi F; Pasini FL; Capecchi PL; Montanaro F; Belli R; Lattanzi M; Piccirella S; Montomoli E; Ahmed SS; Rappuoli R; Del Giudice G; Finco O; Castellino F; Galli G
    Vaccine; 2012 Jun; 30(27):4086-94. PubMed ID: 22521851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
    Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
    Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
    Alam S; Sant AJ
    J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.
    Nayak JL; Richards KA; Yang H; Treanor JJ; Sant AJ
    J Infect Dis; 2015 May; 211(9):1408-17. PubMed ID: 25378637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.
    DiPiazza AT; Fan S; Rattan A; DeDiego ML; Chaves F; Neumann G; Kawaoka Y; Sant AJ
    J Immunol; 2019 Sep; 203(6):1502-1508. PubMed ID: 31399519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.